ACTH(4-7)-Derived Heptapeptide
Semax is an ACTH(4-7)-derived heptapeptide with a C-terminal Pro-Gly-Pro sequence, represented as Met-Glu-His-Phe-Pro-Gly-Pro in peptide literature.
Product Procurement
Research-use catalog items with clear ordering, product context, and documentation support.
Semax – 10mg
$34.99
Product estimate
- FORMAT
- Lyophilized Powder
- NET VIAL CONTENT
- 10mg
- CATEGORY
- Peptides
- SKU
- ALS-SEMAX-10MG
In stock
Research Use Notice
For laboratory research use only. Not for human or animal use or consumption. Not for diagnostic, therapeutic, or veterinary use. Product documentation and certificates of analysis do not establish safety or suitability for these uses.
Product Intelligence
Semax Peptide Profile
ACTH(4-7)-derived regulatory heptapeptide research material supplied as 10mg lyophilized Semax.
10mg Lyophilized Material
This catalog entry identifies a 10mg lyophilized presentation. Form-specific identity and lot details should be confirmed against the product and lot documentation supplied through Standards.
Regulatory-Peptide Chemistry Models
Semax appears in laboratory literature involving regulatory-peptide chemistry, peptide-metal coordination, cell-based assays, and peptide-signaling models. This context is limited to research classification.
- ClassRegulatory heptapeptide
- SequenceMet-Glu-His-Phe-Pro-Gly-Pro
- IdentifierPubChem CID 9811102
- Presentation10mg lyophilized material
Documentation
Verification & Documentation
Documentation is handled by product and lot. Use Standards to search for a matching record; if none appears, contact support with the product name, SKU, and lot number.